Evidence map›Paper›PMID 38665939›Full record

ArticleNature cardiovascular research2023

Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy.

Eirini Kyriakopoulou, Danielle Versteeg, Hesther de Ruiter, Ilaria Perini, Fitzwilliam Seibertz, Yannic Döring, Lorena Zentilin, Hoyee Tsui, Sebastiaan J van Kampen, Malte Tiburcy and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Biologics for cardiovascular diseases: from bench to bedside.Signal transduction and targeted therapy · 2026
    Review
  9. Article
  10. Review
  11. Disease models and AAV therapies ofMolecular therapy. Advances · 2026
    Review
  12. Review
  13. Article
  14. Gene therapy for cardiac arrhythmias.Nature reviews. Cardiology · 2026
    Review
  15. Article
  16. Gene Therapy for Inherited Cardiac Arrhythmias.Journal of cardiovascular translational research · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Eirini KyriakopoulouHubrecht Institute-KNAW and Utrecht University Medical Center, Utrecht, the Netherlands.ORCID 0000-0002-4815-5832
Danielle VersteegHubrecht Institute-KNAW and Utrecht University Medical Center, Utrecht, the Netherlands.
Hesther de RuiterHubrecht Institute-KNAW and Utrecht University Medical Center, Utrecht, the Netherlands.
Ilaria PeriniHubrecht Institute-KNAW and Utrecht University Medical Center, Utrecht, the Netherlands.
Fitzwilliam SeibertzInstitute of Pharmacology and Toxicology, University Medical Center Gottingen (UMG), Göttingen, Germany.ORCID 0000-0002-8554-5186
Yannic DöringInstitute of Pharmacology and Toxicology, University Medical Center Gottingen (UMG), Göttingen, Germany.
Lorena ZentilinInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Hoyee TsuiHubrecht Institute-KNAW and Utrecht University Medical Center, Utrecht, the Netherlands.ORCID 0000-0001-7834-6034
Sebastiaan J van KampenHubrecht Institute-KNAW and Utrecht University Medical Center, Utrecht, the Netherlands.
Malte TiburcyInstitute of Pharmacology and Toxicology, University Medical Center Gottingen (UMG), Göttingen, Germany.
Tim MeyerInstitute of Pharmacology and Toxicology, University Medical Center Gottingen (UMG), Göttingen, Germany.
Niels VoigtInstitute of Pharmacology and Toxicology, University Medical Center Gottingen (UMG), Göttingen, Germany.ORCID 0000-0001-8230-2341
van J Peter TintelenDepartment of Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands.ORCID 0000-0003-3854-6749
Wolfram H ZimmermannInstitute of Pharmacology and Toxicology, University Medical Center Gottingen (UMG), Göttingen, Germany.
Mauro GiaccaInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.ORCID 0000-0003-2927-7225
Eva van RooijHubrecht Institute-KNAW and Utrecht University Medical Center, Utrecht, the Netherlands.ORCID 0000-0002-2026-9408
Utrecht University · NLUniversitätsmedizin Göttingen · DEGerman Center for Neurodegenerative Diseases · DEInternational Centre for Genetic Engineering and Biotechnology · ITKing's College London · GBNanion (Germany) · DEUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arrhythmogenic cardiomyopathy is a severe cardiac disorder characterized by lethal arrhythmias and sudden cardiac death, with currently no effective treatment. Plakophilin 2 (

Indexed as

CardiomyopathiesGenetic vectors

Identifiers

PMID38665939
PMCPMC11041734
OpenAlexW4389439866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.